Natera Inc (NTRA) Stock Analysis

Natera Inc (NTRA) is a publicly traded company in the HEALTHCARE sector. It trades at $212.73, carries a market capitalization of $31.34B. This page summarizes the public market data, fundamentals, and frequently asked questions for NTRA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

Market Sentiment

Natera Inc currently has a Bullish sentiment score of 0.30.

About Natera Inc

Natera, Inc. (NTRA) is a prominent diagnostic company based in San Carlos, California, dedicated to revolutionizing the use of genetic information for improved healthcare outcomes. Specializing in molecular testing across key sectors such as reproductive health, oncology, and organ transplant management, Natera utilizes cutting-edge technologies to deliver accurate and comprehensive genetic insights. Its extensive portfolio and innovative pipeline underscore the company’s commitment to enhanc...

GNG Research Analysis

GNG Research scores Natera Inc (NTRA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NTRA.

Frequently Asked Questions

Does NTRA pay dividends?

Natera Inc (NTRA) does not currently pay a regular dividend.

What is NTRA's market cap?

Natera Inc (NTRA) has a market capitalization of $31.34B with a current stock price of $212.73.